Inauguration of NIDD, the Neuroimmunology Drug Development Summit

The Neuroimmunology Drug Development Summit, or NIDD, will be held in Boston, MA, from April 16-18 2019. This new Hanson Wade event is aimed at experts looking to target chronic neuroinflammation in neurodegenerative disorders. It will enable them understand the pathology, validate effective neuroimmunological drug targets and develop more predictive preclinical models.

An industry-focused meeting

NIDD is the industry’s first meeting dedicated to targeting neuroimmunological mechanisms in order to develop clinically efficacious therapeutics.

To achieve this, the agenda will allow delegates to learn how to:

  • Deepen their knowledge of neuro-immune biology and pathology
  • Validate identified genetic neuroimmunological targets to pursue those with clinical potential
  • Establish robust biomarkers of neuroinflammation for early detection and to monitor disease progression
  • Explore established and novel preclinical models to better recapitulate human disease states
  • Optimize drug delivery and targeting neuroinflammation using blood-brain barrier technologies to increase target engagement

A meeting point for the field’s experts

This event will gather 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai, making it a unique opportunity to network with the experts of the industry. The high concentration of scientists who face similar challenges make NIDD so essential to the development of the field. The scientific community will gather to discuss the future of neuroimmunology and how it translates into drug development strategies to find efficient therapeutics targeting neuroinflammation.

  • NIDD, April 16-18 2019, Boston, MA.

The event is comprised of a full day of Workshops on April 16, followed by a two-day conference. For any additional information, please contact [email protected] or download the full event guide.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Neuroimmunology Drug Development. (2019, June 19). Inauguration of NIDD, the Neuroimmunology Drug Development Summit. News-Medical. Retrieved on October 18, 2019 from https://www.news-medical.net/news/20190405/Inauguration-of-NIDD-the-Neuroimmunology-Drug-Development-Summit.aspx.

  • MLA

    Neuroimmunology Drug Development. "Inauguration of NIDD, the Neuroimmunology Drug Development Summit". News-Medical. 18 October 2019. <https://www.news-medical.net/news/20190405/Inauguration-of-NIDD-the-Neuroimmunology-Drug-Development-Summit.aspx>.

  • Chicago

    Neuroimmunology Drug Development. "Inauguration of NIDD, the Neuroimmunology Drug Development Summit". News-Medical. https://www.news-medical.net/news/20190405/Inauguration-of-NIDD-the-Neuroimmunology-Drug-Development-Summit.aspx. (accessed October 18, 2019).

  • Harvard

    Neuroimmunology Drug Development. 2019. Inauguration of NIDD, the Neuroimmunology Drug Development Summit. News-Medical, viewed 18 October 2019, https://www.news-medical.net/news/20190405/Inauguration-of-NIDD-the-Neuroimmunology-Drug-Development-Summit.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post